A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization

NCT01941446 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Healthy Subjects

Interventions

DRUG: Eravacyline, Moxifloxacin, and placebo

Sponsor

Tetraphase Pharmaceuticals, Inc